A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Flonase Patient, Information, Instructions - Fluticasone propionate
Flonase Patient, Information, Instructions - Fluticasone propionate
Information for Patients
Patients being treated with FLONASE Nasal Spray should receive
the following information and instructions. This information is intended to aid them in the safe
and effective use of this medication. It is not a disclosure of all possible adverse or intended
effects.
Patients should be warned to avoid exposure to chickenpox or measles and, if exposed, to
consult their physician without delay.
Patients should use FLONASE Nasal Spray at regular intervals for optimal effect. Some
patients (12 years of age and older) with seasonal allergic rhinitis may find as-needed use of
200 mcg once daily effective for symptom control (see Clinical Trials).
A decrease in nasal symptoms may occur as soon as 12 hours after starting therapy with
FLONASE Nasal Spray. Results in several clinical trials indicate statistically significant
improvement within the first day or two of treatment; however, the full benefit of FLONASE
Nasal Spray may not be achieved until treatment has been administered for several days. The
patient should not increase the prescribed dosage but should contact the physician if symptoms
do not improve or if the condition worsens.
For the proper use of FLONASE Nasal Spray and to attain maximum improvement, the
patient should read and follow carefully the patient.s instructions accompanying the product.
top
